Hematopathology Practice Questions

Q: To replenish the inventory, blood banks routinely issue blood packets which are close to the expiry date. Which of the following will be the closest to expiry date, according to the anticoagulant used and the method of storage of the packet:

SAGM, 25 days with irradiation. ***SAGM, 25 days with irradiation*** - **SAGM** (Saline-Adenine-Glucose-Mannitol) is an additive solution that extends the storage life of red blood cells significantly. - While SAGM usually allows for storage up to **42 days**, if the blood is **irradiated**, the shelf life is reduced to **28 days from collection or 14 days from irradiation, whichever is sooner**. Given the options, 25 days with irradiation falls within this reduced shelf life, making it the closest to expiry among the provided choices (implying the Irradiation was done earlier). *ACD, 14 days* - **ACD** (Acid Citrate Dextrose) is an older anticoagulant primarily used for apheresis products. - Red blood cells collected with ACD typically have a maximum storage duration of **21 days**. While 14 days is within this, other anticoagulant-additive combinations offer longer storage, and this option is not the closest to expiry when considering the maximum allowed. *CPDA, 27 days* - **CPDA** (Citrate Phosphate Dextrose Adenine) provides a standard shelf life of **35 days** for red blood cells. - While 27 days represents blood that has been stored for a significant period, it still has 8 more days until its maximum expiry, making it less "close to expiry" than the irradiated SAGM option which would expire sooner. *SAGM, 35 days* - **SAGM** (Saline-Adenine-Glucose-Mannitol) allows for the storage of red blood cells for up to **42 days** from collection. - At 35 days, a unit stored in SAGM still has 7 days until its maximum expiry date (if not irradiated), making it less "close to expiry" than a unit that had been irradiated.

Q: Which of the following is not expressed in majority of cases of pediatric B-cell acute lymphoblastic leukemia?

CD7. ***CD7*** - **CD7** is a **T-cell associated antigen** and is typically **not expressed** on B-cell acute lymphoblastic leukemia (ALL) cells [1]. - Its presence would suggest a **T-cell ALL** or an atypical mixed phenotype leukemia, rather than a B-cell ALL. *Terminal deoxynucleotidyl transferase (TdT)* - **TdT** is a **nuclear enzyme** that adds random nucleotides to V(D)J gene segments during lymphoid development and is a **marker of immaturity** in both B and T cell lymphoblasts [2]. - It is **expressed in the majority of B-cell ALL cases** and is crucial for diagnosis. *CD19* - **CD19** is an **early and pan-B-cell marker** that is consistently expressed by B-cell lymphoblasts throughout their development [1]. - It is a **key diagnostic marker** for B-cell ALL. *CD10* - **CD10**, also known as **common acute lymphoblastic leukemia antigen (CALLA)**, is expressed in most progenitor and pre-B ALLs [1]. - Its presence is an important marker used in the immunophenotyping of **B-cell ALL**, particularly the common ALL subtype [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 598. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 599-600.

Q: t(2,8) is associated with:

B cell ALL. ***B cell ALL*** - The translocation **t(2;8)(p11;q24)** is a **variant cytogenetic abnormality** specifically associated with **Burkitt lymphoma/leukemia**, a highly aggressive form of mature B-cell neoplasm, which can present as B-cell ALL. [1] - This variant translocation (occurring in ~15% of Burkitt lymphoma cases) leads to the **dysregulation of the MYC oncogene** on chromosome 8q24 due to its juxtaposition with the **kappa (κ) immunoglobulin light chain gene (IGK)** on chromosome 2p11. [1] - The most common translocation in Burkitt lymphoma is **t(8;14)(q24;q32)** involving MYC and the immunoglobulin heavy chain gene IGH (~80% of cases), while **t(8;22)** involving the lambda light chain occurs in ~5% of cases. [1] *T cell ALL* - T-cell ALL is primarily associated with translocations involving **T-cell receptor genes (e.g., TCRα/δ on 14q11, TCRβ on 7q34)** and various oncogenes like *TAL1*, *LMO1*, *LMO2*, *HOXA*, and *NKX2-5*. - It does not typically involve the **t(2;8) translocation**. *CML* - **Chronic Myeloid Leukemia (CML)** is classically defined by the presence of the **Philadelphia chromosome**, an acquired reciprocal translocation **t(9;22)(q34;q11)**. - This translocation results in the formation of the **BCR-ABL1 fusion gene**, which encodes a constitutively active tyrosine kinase. *CLL* - **Chronic Lymphocytic Leukemia (CLL)** is most frequently associated with cytogenetic abnormalities such as **deletions of 13q14, 11q22-23 (ATM gene), and 17p13 (TP53 gene)**, and **trisomy 12**. - The **t(2;8) translocation** is not characteristic of CLL. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 324-325.

Q: Which one of the following blood fractions is stored at -18°C?

Cryoprecipitate. ***Cryoprecipitate*** - **Cryoprecipitate** contains high concentrations of **Factor VIII**, **von Willebrand factor**, **Factor XIII**, and **fibrinogen**, which are unstable at room temperature [1]. - Storage at **-18°C or colder** is essential to maintain the activity and stability of these coagulation factors for up to one year. *Packed red cells* - **Packed red cells** are typically stored at **2-6°C** for up to 42 days, not frozen, as freezing would damage the red blood cells. - Their primary function is to increase **oxygen-carrying capacity** in patients with anemia or acute blood loss. *Human albumin* - **Human albumin** is a stable protein and is typically stored at **room temperature (2-25°C)**, as freezing is not required to preserve its function. - It is used for **volume expansion** and to maintain **oncotic pressure** in conditions like hypovolemia or hypoalbuminemia. *Platelet concentrate* - **Platelet concentrates** must be stored at **20-24°C** with continuous agitation for up to 5-7 days to maintain their viability and function [2]. - Freezing would irreversibly damage the platelets, making them ineffective for treating **thrombocytopenia** or platelet dysfunction [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 582-583. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 581-582.

Q: In polycythemia vera all are true except

High ESR. ***High ESR*** - In **polycythemia vera**, the **increased red blood cell mass** leads to **hyperviscosity** and often a **decreased erythrocyte sedimentation rate (ESR)**, as the red blood cells settle more slowly due to hindrance. - A high ESR would be **atypical** for polycythemia vera and would suggest an underlying inflammatory process or another condition. *Increased leukocyte alkaline phosphatase* - **Leukocyte alkaline phosphatase (LAP) score** is typically **increased** in polycythemia vera, reflecting the **overproduction of mature neutrophils**. - This is a distinguishing feature from disorders like **chronic myeloid leukemia (CML)**, where the LAP score is low [3]. *Thrombocytosis* - **Thrombocytosis** (elevated platelet count) is a common finding in polycythemia vera due to the **panmyelosis** associated with the disease [1], [3]. - The **JAK2V617F mutation**, frequently present in PV, stimulates megakaryocyte production, leading to increased platelets [1]. *Decreased levels of erythropoietin* - In polycythemia vera, red blood cell production is **independent of erythropoietin**, leading to a **suppressed** or **very low erythropoietin level** in response to the high red cell mass [1], [2]. - This differentiates PV from **secondary polycythemia**, where erythropoietin levels are elevated [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 614-615. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 663-664. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 626-627.

Q: Lead poisoning is characterised by:

Microcytic anaemia. ***Microcytic anaemia*** - Lead poisoning inhibits enzymes involved in **heme synthesis**, leading to impaired hemoglobin production. [1] - This results in the formation of smaller red blood cells with reduced hemoglobin content, hence **microcytic** (small cell) and often **hypochromic** (pale cell) anemia. *Eosinophilic stippling of WBC* - **Eosinophilic stippling** refers to the presence of fine, reddish-pink granules within eosinophils, which is a normal characteristic of these cells. - **Basophilic stippling** of red blood cells, not eosinophilic stippling of WBCs, is a characteristic finding in lead poisoning due to ribosomal aggregation. *Normochromic normocytic anaemia* - This type of anemia involves red blood cells that are normal in size and hemoglobin content, often seen in conditions like **acute blood loss** or **chronic kidney disease**. - Lead poisoning typically impairs hemoglobin synthesis, leading to **microcytic** and often **hypochromic** red cells. [1] *Hypochromic normocytic anaemia* - **Hypochromic normocytic anemia** means the red blood cells are pale (low hemoglobin) but normal in size. - While lead poisoning can cause hypochromia, it primarily leads to **microcytosis** (small red blood cells) due to the impaired heme synthesis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 418-419.

Q: In APML (Acute Promyelocytic Leukemia), all of the following are seen except:

CD 15/34 both seen in same cell. ***CD 15/34 both seen in same cell*** - This statement is incorrect because **Acute Promyelocytic Leukemia (APML)** is characterized by **CD34 negativity**, meaning CD34 is typically absent in APML cells. - While **CD15 may be positive** in APML, **CD34 is negative** in the vast majority of cases (unlike other AML subtypes where CD34 is often positive). - Therefore, **CD15 and CD34 are NOT both seen in the same cell** in APML. - The disease involves **immature myeloid cells** at the promyelocyte stage, which are beyond the most primitive stem cell stage (hence the lack of CD34 expression). *Retinoic acid is used in treatment* - **All-trans retinoic acid (ATRA)** is a cornerstone of treatment for APML. - ATRA induces differentiation of the **promyelocytes**, which helps overcome the **differentiation block** caused by the PML-RARA fusion protein. *15/17 translocation may be seen* - The characteristic genetic abnormality in APML is the **t(15;17) translocation** [1]. - This translocation results in the fusion of the **PML (promyelocytic leukemia) gene** on chromosome 15 with the **RARA (retinoic acid receptor alpha) gene** on chromosome 17 [2]. *Associated with Disseminated intravascular coagulation (DIC)* - APML is frequently associated with a high risk of developing **Disseminated Intravascular Coagulation (DIC)** [1]. - The abnormal promyelocytes release **procoagulant substances** that activate the coagulation cascade, leading to severe bleeding and thrombosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 620. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 605-607.

Q: Most common cause of febrile non haemolytic transfusion reaction?

HLA mismatch. ***HLA mismatch*** - **Febrile non-hemolytic transfusion reactions (FNHTR)** are primarily caused by the recipient's antibodies reacting against donor leukocyte antigens (HLAs) [1]. - This reaction leads to the release of **pyrogenic cytokines** from donor leukocytes stored in the blood product, causing fever and chills [1]. *Rh mismatch* - **Rh mismatch** primarily causes **hemolytic transfusion reactions**, characterized by red blood cell destruction, not just fever without hemolysis [1]. - This type of reaction is typically severe and involves antibody-mediated red cell lysis [1]. *ABO mismatch* - **ABO mismatch** leads to the most severe and often fatal **acute hemolytic transfusion reactions**, involving rapid intravascular hemolysis [1]. - This is a direct immune response against incompatible red blood cell antigens, resulting in hemoglobinuria, renal failure, and shock, not just fever [1]. *All of the options* - This option is incorrect because while all listed conditions relate to transfusion, only **HLA mismatch** commonly causes FNHTRs. - **Rh and ABO mismatches** are associated with distinct and more severe hemolytic reactions.

Question 1

To replenish the inventory, blood banks routinely issue blood packets which are close to the expiry date. Which of the following will be the closest to expiry date, according to the anticoagulant used and the method of storage of the packet:

Accepted Answer

SAGM, 25 days with irradiation

Answer

ACD, 14 days

Answer

CPDA, 27 days

Answer

SAGM, 35 days

Question 2

Which of the following is not expressed in majority of cases of pediatric B-cell acute lymphoblastic leukemia?

Accepted Answer

CD7

Answer

Terminal deoxynucleotidyl transferase (TdT)

Answer

CD19

Answer

CD10

Question 3

t(2,8) is associated with:

Accepted Answer

B cell ALL

Answer

T cell ALL

Answer

CML

Answer

CLL

Question 4

Which one of the following blood fractions is stored at -18°C?

Accepted Answer

Cryoprecipitate

Answer

Packed red cells

Answer

Human albumin

Answer

Platelet concentrate

Question 5

In polycythemia vera all are true except

Accepted Answer

High ESR

Answer

Increased leukocyte alkaline phosphatase

Answer

Thrombocytosis

Answer

Decreased levels of erythropoietin

Question 6

Lead poisoning is characterised by:

Accepted Answer

Microcytic anaemia

Answer

Eosinophilic stippling of WBC

Answer

Normochromic normocytic anaemia

Answer

Hypochromic normocytic anaemia

Question 7

All of the following statements about Lupus Anticoagulant are true, EXCEPT:

Accepted Answer

Thrombotic spells can be followed by severe life threatening hemorrhage

Answer

May present with Recurrent Abortions

Answer

May occur with minimal clinical manifestations

Answer

May present with an isolated prolongation of APTT

Question 8

In APML (Acute Promyelocytic Leukemia), all of the following are seen except:

Accepted Answer

CD 15/34 both seen in same cell

Answer

Retinoic acid is used in treatment

Answer

15/17 translocation may be seen

Answer

Associated with Disseminated intravascular coagulation (DIC)

Question 9

Radiation is most commonly associated with which of the following cancer?

Accepted Answer

Leukemia

Answer

Lymphoma

Answer

Lung carcinoma

Answer

Osteosarcoma

Question 10

Most common cause of febrile non haemolytic transfusion reaction?

Accepted Answer

HLA mismatch

Answer

Rh mismatch

Answer

ABO mismatch

Answer

All of the options

Hematopathology — MCQs

Hematopathology — MCQs

On this page

Practice by Chapter

Want unlimited practice?